HIT Consultant January 28, 2020
Fred Pennic

– StartX company, Eko, announced today that the FDA has cleared Eko’s AFib and heart murmur detection algorithms, making it the first AI-powered stethoscope to screen for serious heart conditions.

– Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool.

Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, announced today that the U.S. Food and Drug Administration has cleared a suite of algorithms that, when combined with Eko’s digital stethoscopes will enable healthcare providers in the U.S. to more accurately screen for heart conditions during routine physical exams. If left undiagnosed, these heart conditions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, FDA, Govt Agencies, Physician, Provider, Regulations, Technology, Wearables
Related Articles:
Q&A: Bring your own device: How patients own tech is being used in clinical trials
AR and VR Have Potential to Reshape Wearable Tech Landscape
Ultrahuman Opens U.S. Manufacturing Facility for Wearable Rings
The Iyo One earbuds are the latest in wearable AI
Emerging Trends in Pain Management Technologies

Share This Article